Latest News

 Filter by Provider

Mahadev Book ID platform features guide provides an overview of the main account and navigation features. It covers profile management, login access, verif

Sarepta Therapeutics (NASDAQ:SRPT) outlined plans to stabilize demand for its ELEVIDYS gene therapy while advancing RNA-based programs for facioscapulohumeral muscular dystrophy, or FSHD, and myotonic dystrophy type 1, or DM1, during a Morgan Stanley Global Healthcare Conference fireside chat. Chie

Jai Club Registration: Creating a More Organized Start to Online GamingThe first step toward exploring an online gaming platform is often creating an accou

Link building has changed significantly over the years. In the past, websites could sometimes improve their search visibility simply by collecting a large

The athletic footwear giant reported a notable insider sale amid nearly a 50% decline in its stock price over the past year.

Modern manufacturing is increasingly focused on lightweight structures, dependable joints, and efficient assembly processes. A self piercing rivet machine

AI robots can create many millionaires, but Tesla may not be the best way to play it.

Managing a medical practice involves much more than providing quality patient care. Healthcare providers must also handle claims, coding, payment posting,

Micron's stock is off its all-time high, but not for long.

51 Game: Smart Account Navigation and Safe Gaming GuideFinding your way around an online gaming platform is easier when you understand how account access,

XAUUSD: SELL 4306.11-4360.01, TP1-4252.21, TP2-4086.71.A month without swaps on majors! Learn moreLong-term trend: long. The maximum accumulation of volume

Biogen (NASDAQ:BIIB) is reshaping its business around a broader mix of neuroscience, immunology, kidney disease and ophthalmology assets, President and CEO Chris Viehbacher said during a Morgan Stanley event. The company expects a series of late-stage clinical readouts to begin as soon as next quart

The laser manufacturer reported a notable insider sale amid a slide in share price.

8:45 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-md-remain

8:40 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-oii-trigg

8:50 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-eix-the-1

Citadel, Ken Griffin's hedge fund, materially increased its stake in AbbVie; here's why you may want to follow that lead.

8:55 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch Listhttp://buyingbreakouts.com/mon-9-14-ndsn-a-brea

Revolutionize your spine care with the cutting-edge Robotic Endoscopic Spine Surgery, expertly performed by the acclaimed Spine Surgeon, Dr. Andrew Chung.

8:54 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-oke-volat

AI fears are mounting.

Walking into a Brazilian Jiu-Jitsu academy for the first time can feel exciting and slightly intimidating. You may be wondering whether you are fit enough,

There are now over a dozen publicly traded companies with market caps exceeding $1 trillion.

Generating sizable dividends from stocks can help achieve passive income goals or supplement income in retirement.

Viking Therapeutics (NASDAQ:VKTX) said its obesity drug candidate VK2735 has advanced into Phase 3 development following Phase 2 results that showed approximately 15% weight loss from baseline after 13 weeks at the highest tested dose. Speaking at the Morgan Stanley Global Healthcare Conference, Pr

Homebuilder Lennar (NYSE:LEN) will be reporting results this Wednesday after market hours. Here’s what you need to know. Lennar missed analysts’ revenue expe...

Record revenue and margin gains as company diversifies into aerospace and edge data centers.

International divestiture deal and $16M cost savings reshape portfolio strategy.

Motley Fool recommends that investors own 50 stocks for diversification, with results to back that up.

It's not too late to catch up if you're behind your peers. Just don't tarry if you are.

Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Healthcare Conference. Marion McCourt, Regeneron’s EVP and head of commercial, said Dupixent’s growth

L’IA multimodale transforme la manière dont les utilisateurs exploitent l’intelligence artificielle. Capable de comprendre et de combiner plusieurs formats

The 4% rule is a helpful estimate, but a three-layer income plan shows exactly where your next retirement payment comes from.

The best investments are sometimes the simplest.

Bird Construction stock has delivered impressive gains. Here’s how its growing project pipeline could support the next phase of infrastructure growth.

The 2026 TSX30 list features five Canadian technology companies whose average return reached an extraordinary 981%.

This under-the-radar consumer discretionary stock boasts a Superscore of 80 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Executives from Bitcoin mining and digital infrastructure companies said access to energized power, land and data-center development capabilities is creating an opportunity to serve growing artificial intelligence infrastructure demand, while also presenting significant construction, financing and r

Recent pullbacks have created potential opportunities in several quality TSX stocks. Other than dividends, they also offer potential upside if their valuations recover.

How important are terrestrial data centers to SpaceX in the near term?

Defense engineering surged 68% as marine tech declined, reshaping revenue mix.

Scotiabank (BNS) stock offers Canadian banking’s top yield at 3.5%. Here’s how quarterly dividend compounding can snowball your returns over time.

The management team did enough to alleviate some investors' fears about worst-case scenarios for the business.

Revenue is catching up to an expensive valuation.

Investors are skeptical about these optimistic forecasts.

Archer Aviation is one of those high-risk, high-reward type investments.

This stock should only be considered by investors with a high risk tolerance.

AI agents can take more actions than humans, creating increasing demands for cybersecurity.

Customer deposits are helping offset cash flow needs at Oracle.

Demand might fall in the future, but shortages remain for now.